Celltrion, Inc. Stock OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 45,336B 33.11B 28.51B 26.77B 24.43B 45.9B 3,150B 46.23B 317B 123B 1,598B 124B 122B 5,290B | P/E 2026 * |
28.7x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 47.53B 34.72M 29.89M 28.07M 25.62M 48.13M 3.3B 48.47M 333M 129M 1.67B 130M 128M 5.55B | EV / Sales 2026 * |
8.67x | EV / Sales 2027 * | 7.43x |
| Free-Float |
60.59% | Yield 2026 * |
0.4% | Yield 2027 * | 0.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 33.21B | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -1.90% | -3.74% | +415.20% | +499.53% | 44.56B | |
| -0.75% | -0.32% | +41.18% | +16.52% | 43.08B | |
| -2.42% | -3.93% | +7.63% | +72.18% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.78% | -4.80% | +24.71% | +118.40% | 16.77B | |
| +7.27% | +5.36% | - | - | 16.28B | |
| +0.25% | -0.98% | +11.63% | +27.62% | 14.58B | |
| -1.38% | -3.63% | +78.44% | +39.12% | 13.92B | |
| Average | -0.28% | -1.24% | +74.76% | +104.77% | 30.51B | |
| Weighted average by Cap. | -0.76% | -1.05% | +88.77% | +121.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 4B 3.45B 3.24B 2.95B 5.55B 381B 5.59B 38.34B 14.92B 193B 15.03B 14.7B 639B | 6,294B 4.6B 3.96B 3.72B 3.39B 6.37B 437B 6.42B 44.03B 17.13B 222B 17.26B 16.88B 734B |
| Net income | 1,511B 1.1B 950M 892M 814M 1.53B 105B 1.54B 10.57B 4.11B 53.24B 4.14B 4.05B 176B | 1,763B 1.29B 1.11B 1.04B 950M 1.79B 123B 1.8B 12.34B 4.8B 62.14B 4.84B 4.73B 206B |
| Net Debt | 2,199B 1.61B 1.38B 1.3B 1.18B 2.23B 153B 2.24B 15.38B 5.98B 77.47B 6.03B 5.9B 257B | 1,409B 1.03B 886M 832M 759M 1.43B 97.91B 1.44B 9.86B 3.84B 49.65B 3.86B 3.78B 164B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
